Literature DB >> 12463414

Expanding the natural repertoire of protein structure and function.

Spencer J Anthony-Cahill1, Thomas J Magliery.   

Abstract

This review considers chemical and genetic approaches to the modification of protein structure. The historical interest in chemical and site-directed modifications will be briefly covered. Current chemical modification strategies will be presented. Biosynthetic mutagenesis with unnatural aminoacyl-tRNAs and current synthetic peptide ligation technologies will be covered in greater detail. The application of combinatorial genetic methods (e.g. phage display, DNA shuffling) to protein engineering with unnatural amino acids will be briefly discussed, with emphasis on the in vitro evolution of new enzymatic function (i.e. aminoacyl-tRNA synthetases). Throughout the review, the powerful insights gained from the combined use of these technologies will be illustrated by examples that focus on the elucidation of protein-ligand interactions.

Mesh:

Substances:

Year:  2002        PMID: 12463414     DOI: 10.2174/1389201023378102

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  3 in total

Review 1.  Laboratory-directed protein evolution.

Authors:  Ling Yuan; Itzhak Kurek; James English; Robert Keenan
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

Review 2.  A review of combined experimental and computational procedures for assessing biopolymer structure-process-property relationships.

Authors:  Greta Gronau; Sreevidhya T Krishnaji; Michelle E Kinahan; Tristan Giesa; Joyce Y Wong; David L Kaplan; Markus J Buehler
Journal:  Biomaterials       Date:  2012-08-28       Impact factor: 12.479

3.  Treatment of glioblastoma multiforme cells with temozolomide-BioShuttle ligated by the inverse Diels-Alder ligation chemistry.

Authors:  Klaus Braun; Manfred Wiessler; Volker Ehemann; Ruediger Pipkorn; Herbert Spring; Juergen Debus; Bernd Didinger; Mario Koch; Gabriele Muller; Waldemar Waldeck
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.